Skip to content
Clinical Trials – home
Verifiedinfo

Individual Practice For Specialized Medical Care Dr. Nikolay Kostadinov EOOD

Bulgaria Ulitsa Stefan Stambolov 132, 8000 Burgas, Bulgaria

  • 1 trial recruiting
  • Chronic obstructive pulmonary disease · Cardiovascular disorder · Chronic kidney disease
  • Adult patients

About Specializations

Individual Practice For Specialized Medical Care Dr. Nikolay Kostadinov EOOD in Burgas, Bulgaria specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Cardiovascular disorder, Chronic kidney disease, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases and Metabolism

At Individual Practice For Specialized Medical Care Dr. Nikolay Kostadinov EOOD in Burgas, clinical research in this area focuses on type 2 diabetes and related cardiovascular disease. These studies are designed to evaluate new treatment approaches for better blood sugar control and to examine whether they can also help reduce longer-term heart-related risks.

  • Testing a new therapy approach for improving glucose control in type 2 diabetes
  • Studying whether treatment can lower the risk of major cardiovascular events
  • Assessing added benefit for people with metabolic disease and related complications

The site’s work in this field reflects a strong interest in therapies that address both daily metabolic control and broader health outcomes.

Respiratory Tract Diseases

Research at this site also covers respiratory conditions, especially chronic obstructive pulmonary disease and asthma. The trials aim to understand how well new or improved inhaled treatments can support lung function, ease symptoms, and improve important health outcomes for adults living with persistent breathing problems.

  • Evaluating treatment effectiveness in COPD and severe respiratory disease
  • Comparing inhaled therapies for better lung function and symptom control
  • Testing a new option for adults with moderate-to-severe uncontrolled asthma

These studies show a clear focus on refining care for chronic airway diseases, with attention to both daily breathing support and longer-term clinical outcomes.

Kidney and Cardiometabolic Research

The clinical trial portfolio includes studies in chronic kidney disease with albuminuria, linking kidney health with broader metabolic and cardiovascular concerns. This work is aimed at finding better ways to reduce kidney-related damage while also addressing risks that often overlap with diabetes and heart disease.

  • Investigating whether a new combination treatment can reduce albuminuria
  • Exploring therapies that may support both kidney and heart health
  • Studying treatment effectiveness in people with overlapping metabolic conditions

This area highlights the site’s interest in integrated care for conditions that commonly occur together and require coordinated treatment strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Stefan Stambolov 1328000 BurgasBulgaria
Recruiting now
1 trial
Conditions studied
5
Partner status
Verified

More sites in BurgasBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:(2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.